Back
Corporate News
Windlas Biotech schedules board meeting November 5 to review financial results
30-Oct-2026, 01:15
Windlas Biotech Limited will hold a board meeting on November 5, 2026, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing. The company’s trading window has been closed since October 1, 2026, and will reopen 48 hours after the financial results are declared.
